A detailed history of Sandia Investment Management LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Sandia Investment Management LP holds 29,950 shares of PRTA stock, worth $306,987. This represents 8.39% of its overall portfolio holdings.

Number of Shares
29,950
Holding current value
$306,987
% of portfolio
8.39%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$6.22 - $9.76 $186,289 - $292,312
29,950 New
29,950 $292,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $481M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Sandia Investment Management LP Portfolio

Follow Sandia Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandia Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sandia Investment Management LP with notifications on news.